IMMUNOMEDICS INC's ticker is IMMU and the CUSIP is 452907108. A total of 144 filers reported holding IMMUNOMEDICS INC in Q2 2017. The put-call ratio across all filers is 0.87 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $200,039,000 | +125.6% | 2,352,580 | -6.0% | 0.04% | +105.3% |
| Q2 2020 | $88,677,000 | +137.2% | 2,502,182 | -9.8% | 0.02% | +90.0% |
| Q1 2020 | $37,383,000 | -65.2% | 2,773,235 | -45.4% | 0.01% | -9.1% |
| Q4 2019 | $107,534,000 | +249.4% | 5,081,988 | +119.0% | 0.01% | +57.1% |
| Q3 2019 | $30,775,000 | -3.6% | 2,320,908 | +0.8% | 0.01% | -12.5% |
| Q2 2019 | $31,926,000 | -18.7% | 2,301,844 | +12.6% | 0.01% | -20.0% |
| Q1 2019 | $39,267,000 | -26.4% | 2,044,131 | -45.4% | 0.01% | +25.0% |
| Q4 2018 | $53,384,000 | +55.2% | 3,741,134 | +126.6% | 0.01% | -20.0% |
| Q3 2018 | $34,391,000 | -6.6% | 1,651,106 | +6.1% | 0.01% | -9.1% |
| Q2 2018 | $36,837,000 | +141.1% | 1,556,311 | +48.8% | 0.01% | +120.0% |
| Q1 2018 | $15,277,000 | -5.1% | 1,045,767 | +5.0% | 0.01% | 0.0% |
| Q4 2017 | $16,100,000 | +26.3% | 996,333 | +9.3% | 0.01% | 0.0% |
| Q3 2017 | $12,748,000 | +66.5% | 911,926 | +5.2% | 0.01% | +66.7% |
| Q2 2017 | $7,655,000 | +47.2% | 867,013 | +7.9% | 0.00% | +50.0% |
| Q1 2017 | $5,200,000 | +100.7% | 803,725 | +13.8% | 0.00% | +100.0% |
| Q4 2016 | $2,591,000 | +28.0% | 706,085 | +13.3% | 0.00% | 0.0% |
| Q3 2016 | $2,025,000 | +42.2% | 623,138 | +1.5% | 0.00% | 0.0% |
| Q2 2016 | $1,424,000 | -0.1% | 614,033 | +7.7% | 0.00% | 0.0% |
| Q1 2016 | $1,425,000 | -17.5% | 570,322 | +1.3% | 0.00% | 0.0% |
| Q4 2015 | $1,727,000 | +82.4% | 562,750 | +2.2% | 0.00% | 0.0% |
| Q3 2015 | $947,000 | -57.3% | 550,628 | +0.8% | 0.00% | 0.0% |
| Q2 2015 | $2,218,000 | +8.5% | 546,521 | +2.3% | 0.00% | 0.0% |
| Q1 2015 | $2,045,000 | -19.2% | 534,110 | +1.3% | 0.00% | -50.0% |
| Q4 2014 | $2,531,000 | +29.3% | 527,336 | +0.1% | 0.00% | +100.0% |
| Q3 2014 | $1,958,000 | +17.8% | 526,592 | +15.6% | 0.00% | 0.0% |
| Q2 2014 | $1,662,000 | -6.0% | 455,479 | +8.4% | 0.00% | 0.0% |
| Q1 2014 | $1,769,000 | +6.6% | 420,301 | +16.4% | 0.00% | 0.0% |
| Q4 2013 | $1,660,000 | -18.6% | 361,043 | +9.6% | 0.00% | -50.0% |
| Q3 2013 | $2,039,000 | +25.6% | 329,338 | +10.3% | 0.00% | +100.0% |
| Q2 2013 | $1,624,000 | – | 298,585 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACUTA CAPITAL PARTNERS, LLC | 4,750,000 | $112,433,000 | 20.02% |
| Avoro Capital Advisors LLC | 17,714,461 | $419,301,000 | 16.14% |
| Foresite Capital Management III, LLC | 2,541,729 | $60,163,000 | 12.96% |
| Foresite Capital Management IV, LLC | 1,231,543 | $29,151,000 | 9.94% |
| Ghost Tree Capital, LLC | 1,250,000 | $29,588,000 | 8.71% |
| NEXTHERA CAPITAL LP | 1,329,104 | $31,460,000 | 4.87% |
| RA Capital Management | 3,119,778 | $73,845,000 | 4.79% |
| DLD Asset Management, LP | 2,682,100 | $63,458,000 | 4.78% |
| Palo Alto Investors LP | 4,803,364 | $113,696,000 | 4.54% |
| DLD Asset Management, LP | 2,411,600 | $57,058,000 | 4.30% |